SAGE Therapeutics Inc (NASDAQ: SAGE)

Sage Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and commercializes novel medicines to treat central nervous system disorders.

Take a look at the 1-year chart of Sage (NASDAQ: SAGE) with the added notations:

SAGE has a key level of support at $140 (green). The stock appears to be making its way back down to that level again, and traders could be able to expect some sort of a bounce. However, if the $140 support level were to break, lower prices should follow.

Continue Reading »

Splunk Inc (NASDAQ: SPLK)

Splunk Inc. provides software solutions that enable organizations to gain real-time operational intelligence in the United States and internationally. Its products enable users to collect, index, search, explore, monitor, correlate, and analyze data regardless of format or source.

Take a look at the 1-year chart of Splunk (NASDAQ: SPLK) below with my added notations:

Over the past 5 months SPLK has created a key level of support at $95 (green). That line is also the “neckline” for the stock’s head and shoulders (H&S) reversal pattern. Above the neckline you will notice the H&S pattern itself (red).

Confirmation of the H&S would occur if SPLK were to break the support, and lower prices would be expected from there.

Continue Reading »

Western Alliance Bancorporation (NYSE: WAL)

Western Alliance Bancorporation operates as the holding company for Western Alliance Bank that provides various banking products and related services primarily in Arizona, California, and Nevada.

Take a look at the 1-year chart of Western (NYSE: WAL) with the added notations:

1-year chart of Western (NYSE: WAL)

WAL has a key level of support at $56 (green). The stock has made it back down to that level again, and traders should be able to expect some sort of a bounce. However, if the $56 support level were to break, lower prices should follow.

Continue Reading »

Nasdaq Inc (NASDAQ: NDAQ)

Nasdaq, Inc. provides trading, clearing, marketplace technology, regulatory, securities listing, information, and public and private company services worldwide.

Take a look at the 1-year chart of Nasdaq (NASDAQ: NDAQ) below with added notations:

1-year chart of Nasdaq (NASDAQ: NDAQ)

NDAQ has stalled at the same $96 resistance (red) multiple times over the past couple of months. The stock has recently turned higher, and looks like it may be heading back towards that $96 level now. A solid close above the resistance should lead to another leg higher for NDAQ.

Continue Reading »

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD)

Acadia Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders.

Take a look at the 1-year chart of Acadia (NASDAQ: ACAD) with the added notations:

1-year chart of Acadia (NASDAQ: ACAD)

During the past 4 months, ACAD had formed a very important level of support at $15 (red). Yesterday saw the stock break below that support. Not only does that imply lower prices for ACAD, but also the $15 level will most likely act as resistance on future rallies.

Continue Reading »